TipRanks
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market
6Y4
Vicore Pharma Holding AB
RESEARCH TOOLSreports

Vicore Pharma Holding AB (6Y4) Stock News & Sentiment

3 Followers
Vicore’s IPF Drug Clears Futility Test as ASPIRE Trial Marches Toward 2027 Readout
Premium
Company Announcements
Vicore’s IPF Drug Clears Futility Test as ASPIRE Trial Marches Toward 2027 Readout
9d ago
Vicore Pharma to Spotlight IPF Program at Chardan Healthcare Conference
Premium
Company Announcements
Vicore Pharma to Spotlight IPF Program at Chardan Healthcare Conference
19d ago
Vicore Pharma boosts share capital as board incentives convert to equity
Premium
Company Announcements
Vicore Pharma boosts share capital as board incentives convert to equity
1M ago
Vicore Pharma to Spotlight IPF Program at Stifel Immunology Forum
Premium
Company Announcements
Vicore Pharma to Spotlight IPF Program at Stifel Immunology Forum
1M ago
Vicore Pharma to Highlight IPF Program at Major U.S. Healthcare Conferences
Premium
Company Announcements
Vicore Pharma to Highlight IPF Program at Major U.S. Healthcare Conferences
2M ago
Vicore Pharma to Highlight ATRAG Pipeline at Pareto Healthcare Conference
Premium
Company Announcements
Vicore Pharma to Highlight ATRAG Pipeline at Pareto Healthcare Conference
2M ago
Vicore Pharma Showcases Buloxibutid IPF Data at ERS 2026 as Phase 2b Trial Advances
Premium
Company Announcements
Vicore Pharma Showcases Buloxibutid IPF Data at ERS 2026 as Phase 2b Trial Advances
2M ago
More DE:6Y4 News >

6Y4 News on the Web

Cantor Fitzgerald Reaffirms Their Buy Rating on Vicore Pharma Holding AB Sponsored ADR (VCRE)
TipRanks News
Bullish
Vicore Pharma initiated with a Buy at Jefferies
TipRanks News
Bullish
Vicore Pharma to Spotlight IPF Program at Stifel Immunology Forum
TipRanks News
Bullish
Vicore Pharma to Highlight IPF Program at Major U.S. Healthcare Conferences
TipRanks News
Bullish
Vicore Pharma Showcases Buloxibutid IPF Data at ERS 2026 as Phase 2b Trial Advances
TipRanks News
Bullish
Vicore Pharma Issues Comprehensive Q2 2026 Interim Report
TipRanks News
Bullish
6Y4 Earnings this Week: How Will it Perform?
TipRanks News
Neutral
Vicore Pharma to Join Leerink Therapeutics Forum Amid Progress in IPF Program
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:6Y4
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:6Y4’s Media Buzz Sentiment?
1 articles about DE:6Y4 were published this week. In an average week, 1 articles are published.
    What is DE:6Y4’s weekly average amount of articles?
    In an average week, 1 articles about DE:6Y4 are published.
      What is DE:6Y4’s News Sentiment?
      100% of articles about DE:6Y4 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CNCCentene
        GMABGenmab
        LHLabcorp Holdings
        KIDSOrthoPediatrics
        DXCMDexcom
        Showing the stocks with the most bullish news sentiment over the past week